Patent intelligence · US
US 7666989
Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof
Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof
Patent details — US 7666989
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 23, 2010
- Expiration
- Feb 18, 2030
- Applicant
- Beijing Sunbio Biotech Co. Ltd.
- Claims
- 7
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00
Quick answer
US 7666989 (Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof) is held by Beijing Sunbio Biotech Co. Ltd.. Status: granted. Granted Feb 23, 2010. Expires Feb 18, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Beijing Sunbio Biotech Co. Ltd.
- Grant date
- Expiration
- Claims
- 7
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00
More from Beijing Sunbio Biotech Co. Ltd.
Related pharmaceutical patents in our USPTO index.
-
US 12234288
Immunogenic arginase 2 polypeptides
granted -
US 12233103
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 12215135
PDL2 compounds
granted -
US 12194081
ARGINASE1 polypeptides
granted -
US 12187782
PDL1 peptides for use in cancer vaccines
granted -
US 12077785
Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof
granted -
US 11981944
Immunogenic arginase peptides
granted -
US 11878053
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof
granted
Frequently asked questions
What is US patent 7666989?
US 7666989 (Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof) is held by Beijing Sunbio Biotech Co. Ltd.. Status: granted. Granted Feb 23, 2010. Expires Feb 18, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7666989?
Beijing Sunbio Biotech Co. Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 21 pharmaceutical patents for this assignee.
When does US 7666989 expire?
Our index shows an expiration date of Feb 18, 2030 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.